In addition, the rest of the cancer risk pathway: Mitotic Prometaphase pathway and Cyclin B2 mediated events pathway, which usually show abnormal activities and will result in poor prognosis19 in patients of breast cancer. This evidence concerns the gene CCNB2 and breast cancer.